| Report ID | 277659 |
| Drug Identification Number | 02482223 |
| Brand name | SANDOZ RIVAROXABAN |
| Common or Proper name | RIVAROXABAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVAROXABAN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100FCT |
| ATC code | B01AF |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2026-02-09 |
| Estimated end date | 2026-02-27 |
| Actual end date | 2026-03-02 |
| Shortage status | Resolved |
| Updated date | 2026-03-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2026-03-03 | French | Compare |
| v7 | 2026-03-03 | English | Compare |
| v6 | 2026-03-02 | French | Compare |
| v5 | 2026-03-02 | English | Compare |
| v4 | 2026-02-23 | French | Compare |
| v3 | 2026-02-23 | English | Compare |
| v2 | 2026-02-09 | French | Compare |
| v1 | 2026-02-09 | English | Compare |
Showing 1 to 8 of 8